SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Apyx Medical Corporation (NASDAQ: APYX)PRNewsWire · 3 days ago
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026GlobeNewsWire · 3 days ago
Apyx Medical Corporation to Participate in Upcoming Investor ConferencesGlobeNewsWire · 4 days ago
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®'s Impact on Skin QualityGlobeNewsWire · Sep 29, 2026
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body ContouringMarketBeat · Aug 11, 2026
Apyx Medical Corporation (NASDAQ:APYX) Receives $6.60 Consensus Target Price from BrokeragesDefense World · Aug 11, 2026Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.08 | -$0.07 | Beat |
| May 7, 2026 | -$0.11 | -$0.05 | Beat |
| Mar 10, 2026 | -$0.06 | -$0.03 | Beat |
| Nov 6, 2025 | -$0.06 | -$0.05 | Beat |
| Aug 7, 2025 | -$0.09 | -$0.09 | Beat |
| May 8, 2025 | -$0.12 | -$0.10 | Beat |